A polybacterial sublingual vaccine, which reduced recurrent UTI rates and had few side effects, could be useful in future clinical practice, according to researchers. J. Curtis Nickel, MD, FRCSC, Emeritus Professor of Urology and Canada Research Chair in Urologic Pain and Inflammation at Queen’s University, told Healio that recurrent UTIs (rUTIs) are a “huge problem,” with